Apramycin Sulfate [65710-07-8]
Order number: 51745110
Part number: AC100071568
£ 30.90*
*Prices without VAT and shipping costs£ 37.08*
*incl. VAT, plus shipping costsPrice Breakdown
Apramycin Sulfate [65710-07-8] serves as a key component in chemical process workflows, featuring a complex molecular structure represented by the formula C21H41N5O11·H2SO4 and a molecular weight of 637.66. This compound exhibits a low Melting Point, with a value of ≤2.0%. As a product-specific offering, Apramycin Sulfate presents a light brown powder or granular material hygroscopic, with a guaranteed assay of ≥450ug/mg, a sulphate content ranging between 26.0% and 33.0%, a maximum water content of 10.0%, and a sulphated ash content of ≤1.0%. Additionally, it contains no more than 7.0% of 3-hydroxyapramycin, 1.0% of Caerulomycin and dipyridyl derivatives, and 5.0% of lividamine/2-deoxystreptamine. This antibiotic derivative is suitable for storage at temperatures between 2 to 8 °C.
- CAS Number: 65710-07-8
- Content of 3-hydroxyapramycin: ≤7.0%
- Content of lividamine/2-deoxystreptamine: ≤5.0%
- Molecular Formula: C21H41N5O11·H2SO4
- Appearance: Light brown powder or granular material hygroscopic
- Melting Point: ≤2.0%
- Assay: ≥450ug/mg
- Molecular Weight: 637.66
| Name | Value | |
|---|---|---|
| CAS | : | 65710-07-8 |
| Assay | : | ≥450ug/mg |
| Water | : | ≤10.0% |
| Sulphate | : | 26.0% - 33.0% |
| Appearance | : | Light brown powder or granular material hygroscopic. |
| Categories | : | Antibiotics Bioactive Small Molecules |
| Impurity A | : | ≤2.0% |
| Impurity B | : | ≤2.0% |
| Product Code | : | 51745110 |
| Product Name | : | Apramycin Sulfate |
| Sulphated Ash | : | ≤1.0% |
| Identification | : | Conforms to reference |
| Storage Details | : | 2 to 8 °C |
| Molecular Weight | : | 637.66 |
| Total Impurities | : | ≤15.0% |
| Molecular Formula | : | C21H41N5O11·H2SO4 |
| Harmonised Tariff Code | : | 2941900000 |
| Any other single impurity | : | ≤2.0% |
| Content of 3-hydroxyapramycin | : | ≤7.0% |
| Caerulomycin and dipyridyl derivatives | : | ≤1.0% |
| Content of lividamine/2-deoxystreptamine | : | ≤5.0% |
